Updated: Jul 3
U of Missouri clinical trial
Soft tissue sarcoma is a common solid tumor for dogs, and often comes back and spreads even after surgery.
The University of Missouri Veterinary Hospital is enrolling canine patients with high-grade soft tissue sarcoma to evaluate a new immunotherapy treatment that boosts the dog's natural immune system more effectively fight cancer.
Watch this short introduction to the study (2 minutes) with
Prof Jeff Bryan (MU) - a veterinary oncologist and Prof Seth Pollack MD (Northwestern University) - a sarcoma immunotherapy expert
MU is enrolling dogs diagnosed with high-grade soft tissue sarcoma. The hope is that the dog may enjoy long-term remission by establishing immune memory. This study may also help guide and improve cancer sarcoma treatments for people.
Visit the University of Missouri clinical trials page:
Learn more about the background of this study:
Watch a summary of the study ( 18 minutes)